An FDA oncology analysis of CD3 bispecific constructs and...

  • Main
  • 2017 / 9
  • An FDA oncology analysis of CD3 bispecific constructs and...

An FDA oncology analysis of CD3 bispecific constructs and first-in-human dose selection

Saber, Haleh, Del Valle, Pedro, Ricks, Tiffany K., Leighton, John K.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Regulatory Toxicology and Pharmacology
DOI:
10.1016/j.yrtph.2017.09.001
Date:
September, 2017
File:
PDF, 598 KB
english, 2017
Conversion to is in progress
Conversion to is failed